-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Oncotelic Therapeutics, Inc. annual/quarterly Revenues history and growth rate for Q3 2023.
- Oncotelic Therapeutics, Inc. Revenues for the quarter ending September 30, 2023 was $70K.
- Oncotelic Therapeutics, Inc. annual Revenues for 2023 was $70K.